{"id":37106,"date":"2026-06-26T05:44:59","date_gmt":"2026-06-26T00:14:59","guid":{"rendered":"https:\/\/atsixty.com\/?p=37106"},"modified":"2026-06-26T05:45:51","modified_gmt":"2026-06-26T00:15:51","slug":"abnormal-uterine-bleeding-palm-coein","status":"publish","type":"post","link":"https:\/\/atsixty.com\/index.php\/obg\/abnormal-uterine-bleeding-palm-coein\/","title":{"rendered":"Abnormal Uterine Bleeding & PALM-COEIN"},"content":{"rendered":"\n\n\n\n\nMorning Rounds \u00b7 Abnormal Uterine Bleeding & PALM-COEIN<\/title>\n<link href=\"https:\/\/fonts.googleapis.com\/css2?family=Playfair+Display:ital,wght@0,400;0,600;0,700;1,400;1,600&family=Source+Serif+4:ital,wght@0,300;0,400;0,600;1,400&display=swap\" rel=\"stylesheet\">\n<style>\n#gyn02 *,#gyn02 *::before,#gyn02 *::after{box-sizing:border-box;margin:0;padding:0}\n#gyn02{\n --ob:#4B3A6E;\n --ob-light:#5F4D85;\n --ob-pale:#EFE9F5;\n --ob-dark:#362952;\n --correct:#2D6B47;--correct-bg:#EAF6EF;--correct-border:#3A9960;\n --wrong:#B83232;--wrong-bg:#FDF0F0;--wrong-border:#E53935;\n --ink:#241B36;--ink-mid:#4A3D63;--ink-soft:#8A7FA0;\n --line:#E0D8EC;--cream:#F8F6FB;--warm:#FCFBFD;\n font-family:'Source Serif 4',Georgia,serif;\n font-size:16px;color:var(--ink);background:var(--cream);\n line-height:1.7;padding:0 0 64px;\n}\n#gyn02 .mr-header{background:var(--ob);color:#F3EFFA;padding:34px 24px 28px;text-align:center}\n#gyn02 .mr-eyebrow{font-size:0.68rem;letter-spacing:0.18em;text-transform:uppercase;font-weight:600;opacity:0.65;margin-bottom:10px}\n#gyn02 .mr-title{font-family:'Playfair Display',serif;font-size:1.75rem;font-weight:700;line-height:1.2;margin-bottom:4px}\n#gyn02 .mr-title em{font-style:italic;font-weight:400;opacity:0.88}\n#gyn02 .mr-subtitle{font-size:0.82rem;opacity:0.7;margin-top:8px;font-style:italic}\n#gyn02 .mr-chips{display:flex;justify-content:center;gap:10px;margin-top:18px;flex-wrap:wrap}\n#gyn02 .mr-chip{background:rgba(255,255,255,0.13);border:1px solid rgba(255,255,255,0.22);border-radius:20px;padding:4px 13px;font-size:0.73rem}\n#gyn02 .mr-sentinel{height:1px}\n#gyn02 .mr-progress{position:fixed;top:0;left:0;right:0;z-index:9999;background:var(--warm);border-bottom:1px solid var(--line);box-shadow:0 2px 12px rgba(36,27,54,0.08);padding:9px 16px;display:none}\n#gyn02 .mr-progress.visible{display:block}\n#gyn02 .mr-prog-inner{max-width:720px;margin:0 auto;display:flex;align-items:center;justify-content:center}\n#gyn02 .mr-pips{display:flex;align-items:center;justify-content:center}\n#gyn02 .mr-pip-wrap{display:flex;align-items:center}\n#gyn02 .mr-pip-line{width:28px;height:2px;background:var(--line);transition:background 0.35s}\n#gyn02 .mr-pip-line.done{background:var(--ob)}\n#gyn02 .mr-pip{width:28px;height:28px;border-radius:50%;border:2px solid var(--line);background:var(--warm);display:flex;align-items:center;justify-content:center;font-size:0.63rem;font-weight:700;color:var(--ink-soft);transition:all 0.3s;flex-shrink:0}\n#gyn02 .mr-pip.correct{background:var(--correct-border);border-color:var(--correct-border);color:#fff}\n#gyn02 .mr-pip.wrong{background:var(--wrong-border);border-color:var(--wrong-border);color:#fff}\n#gyn02 .mr-body{max-width:720px;margin:0 auto;padding:0 16px}\n#gyn02 .mr-case{background:var(--warm);border:1px solid var(--line);border-left:4px solid var(--ob);border-radius:10px;margin:28px 0;overflow:hidden;box-shadow:0 1px 6px rgba(36,27,54,0.05)}\n#gyn02 .mr-case-top{padding:16px 20px 14px;display:flex;gap:14px;align-items:flex-start}\n#gyn02 .mr-num{font-family:'Playfair Display',serif;font-size:2.2rem;font-weight:700;color:var(--ob);opacity:0.16;line-height:1;margin-top:-2px;flex-shrink:0}\n#gyn02 .mr-meta{flex:1}\n#gyn02 .mr-tag{font-size:0.61rem;font-weight:700;letter-spacing:0.14em;text-transform:uppercase;color:var(--ob);opacity:0.75;margin-bottom:5px}\n#gyn02 .mr-stem{font-size:0.94rem;color:var(--ink);line-height:1.72}\n#gyn02 .mr-stem strong{font-weight:600}\n#gyn02 .mr-stem em{font-style:italic}\n#gyn02 .mr-rule{height:1px;background:var(--line);margin:0 20px}\n#gyn02 .mr-opts{padding:12px 20px 16px;display:flex;flex-direction:column;gap:8px}\n#gyn02 .mr-opt{display:flex;align-items:flex-start;gap:11px;padding:10px 14px;border:1.5px solid var(--line);border-radius:8px;cursor:pointer;background:var(--warm);transition:border-color 0.15s,background 0.15s;-webkit-tap-highlight-color:transparent}\n#gyn02 .mr-opt:hover{border-color:var(--ob);background:var(--ob-pale)}\n#gyn02 .mr-opt.locked{cursor:default}\n#gyn02 .mr-opt.locked:hover{border-color:var(--line);background:var(--warm)}\n#gyn02 .mr-opt.correct{border-color:var(--correct-border);background:var(--correct-bg);cursor:default}\n#gyn02 .mr-opt.correct:hover{border-color:var(--correct-border);background:var(--correct-bg)}\n#gyn02 .mr-opt.wrong{border-color:var(--wrong-border);background:var(--wrong-bg);cursor:default}\n#gyn02 .mr-opt.wrong:hover{border-color:var(--wrong-border);background:var(--wrong-bg)}\n#gyn02 .mr-opt.dimmed{opacity:0.35;cursor:default}\n#gyn02 .mr-opt.dimmed:hover{border-color:var(--line);background:var(--warm)}\n#gyn02 .mr-ltr{flex-shrink:0;width:20px;height:20px;border-radius:50%;border:1.5px solid var(--line);display:flex;align-items:center;justify-content:center;font-size:0.62rem;font-weight:700;color:var(--ink-soft);margin-top:2px;transition:all 0.15s}\n#gyn02 .mr-opt.correct .mr-ltr{background:var(--correct-border);border-color:var(--correct-border);color:#fff}\n#gyn02 .mr-opt.wrong .mr-ltr{background:var(--wrong-border);border-color:var(--wrong-border);color:#fff}\n#gyn02 .mr-opt-text{font-size:0.9rem;color:var(--ink-mid);line-height:1.58}\n#gyn02 .mr-opt.correct .mr-opt-text{color:var(--correct);font-weight:600}\n#gyn02 .mr-opt.wrong .mr-opt-text{color:var(--wrong)}\n#gyn02 .mr-exp{display:none;border-top:1px solid #d4c5e8;background:linear-gradient(180deg,#ece4f6 0%,#f4eff9 100%);padding:13px 20px 15px}\n#gyn02 .mr-exp-lbl{font-size:0.61rem;font-weight:700;letter-spacing:0.12em;text-transform:uppercase;color:#3F2D60;margin-bottom:6px}\n#gyn02 .mr-exp-text{font-size:0.86rem;color:#2A1F40;line-height:1.68}\n#gyn02 .mr-exp-text strong{font-weight:600}\n#gyn02 .mr-exp-text em{font-style:italic}\n#gyn02 .mr-img-wrap{margin-top:14px;background:var(--warm);border:1px solid var(--line);border-radius:8px;padding:14px;text-align:center}\n#gyn02 .mr-img-wrap figcaption{font-size:0.73rem;color:var(--ink-soft);font-style:italic;margin-top:8px;line-height:1.4}\n#gyn02 .mr-submit-wrap{text-align:center;padding:28px 16px 8px}\n#gyn02 .mr-btn{background:var(--ob);color:#F3EFFA;border:none;border-radius:8px;padding:13px 44px;font-family:'Playfair Display',serif;font-size:1rem;font-weight:700;cursor:pointer;box-shadow:0 2px 8px rgba(75,58,110,0.28)}\n#gyn02 .mr-btn:hover{background:var(--ob-dark)}\n#gyn02 .mr-score{display:none;background:var(--warm);border:1px solid var(--line);border-top:4px solid var(--ob);border-radius:10px;margin:24px 0 0;box-shadow:0 2px 12px rgba(36,27,54,0.08);overflow:hidden}\n#gyn02 .mr-score-in{padding:28px 24px;text-align:center}\n#gyn02 .mr-score-ey{font-size:0.66rem;letter-spacing:0.14em;text-transform:uppercase;color:var(--ink-soft);margin-bottom:12px;font-weight:600}\n#gyn02 .mr-ring{width:98px;height:98px;border-radius:50%;background:conic-gradient(var(--ob) 0%,var(--line) 0%);display:flex;align-items:center;justify-content:center;margin:0 auto 16px;position:relative}\n#gyn02 .mr-ring::before{content:'';position:absolute;width:76px;height:76px;border-radius:50%;background:var(--warm)}\n#gyn02 .mr-ring-in{position:relative;display:flex;flex-direction:column;align-items:center;line-height:1.2}\n#gyn02 .mr-ring-pct{font-family:'Playfair Display',serif;font-size:1.3rem;font-weight:700;color:var(--ob)}\n#gyn02 .mr-ring-sub{font-size:0.54rem;color:var(--ink-soft);text-transform:uppercase;letter-spacing:0.06em}\n#gyn02 .mr-score-title{font-family:'Playfair Display',serif;font-size:1.15rem;font-weight:700;color:var(--ink);margin-bottom:4px}\n#gyn02 .mr-score-net{font-size:0.9rem;color:var(--ob);font-weight:600;margin-bottom:4px}\n#gyn02 .mr-verdict{font-size:0.83rem;color:var(--ink-soft);font-style:italic;margin-bottom:18px;padding:0 12px}\n#gyn02 .mr-bands{display:flex;justify-content:center;gap:10px;flex-wrap:wrap}\n#gyn02 .mr-band{padding:5px 13px;border-radius:16px;font-size:0.78rem;font-weight:600}\n#gyn02 .mr-band-c{background:var(--correct-bg);color:var(--correct)}\n#gyn02 .mr-band-w{background:var(--wrong-bg);color:var(--wrong)}\n#gyn02 .mr-band-s{background:var(--ob-pale);color:var(--ob)}\n#gyn02 .mr-retry{display:block;margin:18px auto 4px;background:transparent;border:2px solid var(--ob);color:var(--ob);border-radius:8px;padding:9px 28px;font-family:'Playfair Display',serif;font-size:0.92rem;font-weight:700;cursor:pointer}\n#gyn02 .mr-retry:hover{background:var(--ob);color:#F3EFFA}\n@media(max-width:480px){#gyn02 .mr-title{font-size:1.4rem}#gyn02 .mr-num{font-size:1.7rem}#gyn02 .mr-stem{font-size:0.9rem}#gyn02 .mr-opt-text{font-size:0.86rem}}\n<\/style>\n\n<div id=\"gyn02\">\n\n <div class=\"mr-header\">\n <div class=\"mr-eyebrow\">Morning Rounds · Gynaecology Series · Round 02<\/div>\n <div class=\"mr-title\">\n Abnormal Uterine Bleeding &<br><em>PALM-COEIN<\/em>\n <\/div>\n <div class=\"mr-subtitle\">Five cases · Structural & non-structural causes of AUB · Trust your instinct<\/div>\n <div class=\"mr-chips\">\n <span class=\"mr-chip\">5 Cases<\/span>\n <span class=\"mr-chip\">+4 \/ −1 scoring<\/span>\n <span class=\"mr-chip\">Options reshuffled<\/span>\n <\/div>\n <\/div>\n\n <div class=\"mr-sentinel\" id=\"gyn02-sentinel\"><\/div>\n\n <div class=\"mr-progress\" id=\"gyn02-progress\">\n <div class=\"mr-prog-inner\">\n <div class=\"mr-pips\" id=\"gyn02-pips\"><\/div>\n <\/div>\n <\/div>\n\n <div class=\"mr-body\">\n <div id=\"gyn02-cases\"><\/div>\n <div class=\"mr-submit-wrap\">\n <button class=\"mr-btn\" id=\"gyn02-submit\">Submit for Debrief<\/button>\n <\/div>\n <div class=\"mr-score\" id=\"gyn02-score\">\n <div class=\"mr-score-in\">\n <div class=\"mr-score-ey\">Round Complete<\/div>\n <div class=\"mr-ring\" id=\"gyn02-ring\">\n <div class=\"mr-ring-in\">\n <span class=\"mr-ring-pct\" id=\"gyn02-pct\">0%<\/span>\n <span class=\"mr-ring-sub\">net<\/span>\n <\/div>\n <\/div>\n <div class=\"mr-score-title\">Your Debrief<\/div>\n <div class=\"mr-score-net\" id=\"gyn02-net\"><\/div>\n <div class=\"mr-verdict\" id=\"gyn02-verdict\"><\/div>\n <div class=\"mr-bands\">\n <span class=\"mr-band mr-band-c\" id=\"gyn02-ct-c\"><\/span>\n <span class=\"mr-band mr-band-w\" id=\"gyn02-ct-w\"><\/span>\n <span class=\"mr-band mr-band-s\" id=\"gyn02-ct-s\"><\/span>\n <\/div>\n <button class=\"mr-retry\" id=\"gyn02-retry\">↻ New Round<\/button>\n <\/div>\n <\/div>\n <\/div>\n\n<\/div><!-- end #gyn02 -->\n\n<script>\n(function () {\n 'use strict';\n\n var NS = 'gyn02';\n var TOTAL = 5;\n var MAX = 20;\n var LTRS = ['A','B','C','D'];\n\n var QS = [\n\n {\n id: 1,\n tag: 'AUB Classification — PALM-COEIN',\n stem: 'A 34-year-old with regular but heavy cycles is found on transvaginal ultrasound to have a 3 cm fibroid distorting the endometrial cavity (submucosal). Using the PALM-COEIN system, how should this be classified, and what does the classification imply for management?',\n correct: 'This is classified under the \"L\" (Leiomyoma) category as a submucosal fibroid (FIGO type 0-2); cavity-distorting submucosal fibroids correlate most strongly with heavy bleeding among fibroid subtypes, making hysteroscopic myomectomy a reasonable first-line surgical option here',\n opts: [\n 'This is classified under the \"L\" (Leiomyoma) category as a submucosal fibroid (FIGO type 0-2); cavity-distorting submucosal fibroids correlate most strongly with heavy bleeding among fibroid subtypes, making hysteroscopic myomectomy a reasonable first-line surgical option here',\n 'A fibroid of this size causing heavy bleeding should be classified under the \"M\" (Malignancy and hyperplasia) category rather than \"L\", since any fibroid associated with significant blood loss carries a high enough malignant risk to warrant that label without histological confirmation',\n 'All fibroid subtypes, whether submucosal, intramural, or subserosal, are equally likely to cause heavy menstrual bleeding regardless of size, so the specific location noted on ultrasound has no real bearing on either the classification or the choice of management here',\n 'PALM-COEIN classifies bleeding causes by severity of blood loss reported rather than by underlying pathology or anatomy, so this case would be classified by the degree of menorrhagia described rather than by the fibroid\\'s location relative to the endometrial cavity'\n ],\n exp: 'PALM-COEIN splits AUB into <strong>structural<\/strong> causes (Polyp, Adenomyosis, Leiomyoma, Malignancy\/hyperplasia) and <strong>non-structural<\/strong> causes (Coagulopathy, Ovulatory dysfunction, Endometrial, Iatrogenic, Not yet classified). A fibroid falls under \"L\", further subclassified by FIGO type by its relation to the cavity (0–2 submucosal, 3–4 intramural, 5–7 subserosal). <strong>Submucosal fibroids bleed disproportionately<\/strong> because of direct cavity distortion and endometrial surface involvement — which is exactly why location, not just size, drives both the classification and the management choice toward hysteroscopic resection. <br><br>Fibroid size and bleeding severity do <strong>not<\/strong> reclassify a lesion as \"M\" — that category is reserved for confirmed malignancy or hyperplasia on histology, not inferred from blood loss. And PALM-COEIN classifies by <strong>underlying structural cause<\/strong>, not by how heavy the bleeding is reported to be — severity is a clinical descriptor, not the classification axis itself.',\n imgId: null\n },\n\n {\n id: 2,\n tag: 'Anovulatory AUB — Mechanism & Risk',\n stem: 'A 17-year-old, 2 years post-menarche, reports irregular cycles ranging from 18 to 60 days with occasional heavy bleeding. Pelvic ultrasound and coagulation screen are normal. What is the most likely underlying mechanism, and what long-term risk does it carry if left unaddressed?',\n correct: 'This pattern reflects ovulatory dysfunction (anovulatory cycles), common in the first few years post-menarche from an immature hypothalamic-pituitary-ovarian axis; unopposed oestrogen from cycles lacking a corpus luteum, if persistent over years, carries a risk of endometrial hyperplasia and should prompt cycle regulation',\n opts: [\n 'This pattern reflects ovulatory dysfunction (anovulatory cycles), common in the first few years post-menarche from an immature hypothalamic-pituitary-ovarian axis; unopposed oestrogen from cycles lacking a corpus luteum, if persistent over years, carries a risk of endometrial hyperplasia and should prompt cycle regulation',\n 'This pattern is an entirely expected and self-correcting feature of early adolescence carrying no associated long-term risk, so no specific monitoring, follow-up, or intervention is required regardless of how many years the irregular pattern continues beyond menarche',\n 'The irregular heavy bleeding here reflects excess progesterone production from a poorly regulated corpus luteum, and the long-term risk if untreated is progressive endometrial atrophy rather than any proliferative change in the endometrial lining over time',\n 'Despite the normal ultrasound, a structural cause cannot be considered excluded in an adolescent with this bleeding pattern without proceeding to hysteroscopy or pelvic MRI, since ultrasound alone is an insufficient basis for attributing the pattern to ovulatory dysfunction'\n ],\n exp: 'An immature <strong>hypothalamic-pituitary-ovarian axis<\/strong> in the first couple of years post-menarche commonly produces anovulatory cycles — without a corpus luteum, there is no progesterone to oppose oestrogen, leaving the endometrium proliferative and prone to irregular, sometimes heavy, shedding. Persisting unopposed oestrogen exposure over years carries a real <strong>endometrial hyperplasia<\/strong> risk, which is why cycle regulation (cyclical progestins or COCP) is reasonable rather than blanket reassurance. <br><br>Many adolescents do normalise with time, but \"usually self-corrects\" is not the same as \"carries no risk and needs no monitoring\" — persistent or heavy patterns still warrant attention. The mechanism is <strong>unopposed oestrogen, not excess progesterone<\/strong> — getting the direction backwards inverts the entire clinical logic, including which endometrial change to expect. And ultrasound is the appropriate <strong>first-line structural screen<\/strong> at this age; escalating straight to hysteroscopy or MRI without a finding or red flag overshoots the actual pretest probability of structural disease here.',\n imgId: null\n },\n\n {\n id: 3,\n tag: 'Adolescent Menorrhagia — Bleeding Disorder Screen',\n stem: 'A 14-year-old presents with heavy menstrual bleeding present since menarche at age 12, requiring pad changes every 1–2 hours, with easy bruising and occasional nosebleeds on history. What should this history prompt beyond routine gynaecological assessment?',\n correct: 'Heavy bleeding present since menarche, combined with easy bruising and epistaxis, should prompt screening for an underlying bleeding disorder such as von Willebrand disease, since this combination is a recognised red flag, and coagulation studies should be pursued alongside the standard gynaecological evaluation rather than after it',\n opts: [\n 'Heavy bleeding present since menarche, combined with easy bruising and epistaxis, should prompt screening for an underlying bleeding disorder such as von Willebrand disease, since this combination is a recognised red flag, and coagulation studies should be pursued alongside the standard gynaecological evaluation rather than after it',\n 'The bruising and nosebleeds described are most likely incidental findings unrelated to her menstrual complaint, so the evaluation should proceed exactly as it would for any adolescent with heavy bleeding, without specifically pursuing a coagulation workup on the strength of this history alone',\n 'A bleeding disorder workup is reasonable in principle but should only be pursued after structural and hormonal gynaecological causes have first been fully excluded, since coagulation studies are generally considered a second-line investigation reserved for cases unexplained after gynaecological evaluation',\n 'Heavy menstrual bleeding present since menarche is a typical and expected pattern in early adolescence regardless of associated bruising or nosebleeds, so this history does not, on its own, represent a specific indication to pursue coagulation studies at this stage'\n ],\n exp: 'Heavy bleeding <strong>since menarche<\/strong> — as opposed to heavy bleeding that develops later — paired with bruising and epistaxis is the textbook trigger for screening for <strong>von Willebrand disease<\/strong> and other bleeding disorders (PALM-COEIN\\'s \"C\" category). This workup belongs <strong>alongside<\/strong> the gynaecological evaluation, not deferred until other causes are exhausted, because the early-onset pattern itself already raises pretest probability enough to justify simultaneous testing. <br><br>Treating the bruising and epistaxis as <strong>incidental<\/strong> ignores a combination most exam-setters consider a deliberate red flag, not background noise. And calling bleeding-since-menarche a <strong>\"typical and expected\"<\/strong> variant gets the teaching point backwards — that specific onset pattern is precisely what should raise suspicion, not what should be waved off as routine.',\n imgId: null\n },\n\n {\n id: 4,\n tag: 'Fibroid Subtype & Symptom Correlation',\n stem: 'Two women have similarly sized (4 cm) uterine fibroids. One has a submucosal fibroid distorting the endometrial cavity; the other has a subserosal fibroid on the outer uterine surface. Which is more likely to present with heavy menstrual bleeding, and why?',\n correct: 'The submucosal fibroid is more likely to cause heavy bleeding, because its distortion of the endometrial cavity increases endometrial surface area and disrupts normal endometrial vasculature; the subserosal fibroid, despite similar size, is more often asymptomatic or presents with bulk symptoms rather than bleeding',\n opts: [\n 'The submucosal fibroid is more likely to cause heavy bleeding, because its distortion of the endometrial cavity increases endometrial surface area and disrupts normal endometrial vasculature; the subserosal fibroid, despite similar size, is more often asymptomatic or presents with bulk symptoms rather than bleeding',\n 'The subserosal fibroid is more likely to cause heavy menstrual bleeding, because its location on the outer uterine surface compresses the uterine vasculature externally, increasing venous congestion within the endometrium more than a submucosal fibroid of similar size would',\n 'Bleeding severity in uterine fibroids correlates primarily with overall fibroid size rather than its location relative to the endometrial cavity, so two fibroids of the same size would be expected to cause comparable menstrual blood loss regardless of being submucosal or subserosal in position',\n 'A subserosal fibroid, regardless of accompanying findings, should be considered incapable of contributing to menstrual blood loss, so any heavy bleeding occurring alongside one must necessarily be attributed to an entirely separate, undiagnosed cause elsewhere'\n ],\n exp: 'Under the FIGO fibroid subclassification (0–2 submucosal, 3–4 intramural, 5–7 subserosal), <strong>submucosal fibroids bleed disproportionately<\/strong> because of direct endometrial surface involvement and disrupted local vasculature; <strong>subserosal fibroids<\/strong> more typically cause bulk or pressure symptoms and are frequently silent with respect to bleeding. <br><br>Claiming the subserosal fibroid bleeds more by externally compressing vasculature gets the anatomy backwards — it is the cavity-facing fibroid that disrupts the bleeding surface, not the serosal one. <strong>Size alone<\/strong> does not determine bleeding risk — location relative to the cavity is the key variable among same-sized fibroids. That said, subserosal fibroids are not <strong>absolutely incapable<\/strong> of any bleeding contribution either — the correct framing is relative likelihood, not an absolute rule, and overcorrecting to \"never\" is its own kind of trap.',\n imgId: null\n },\n\n {\n id: 5,\n tag: 'AUB Management — First-Line Therapy',\n stem: 'A 38-year-old with regular, ovulatory cycles but objectively confirmed heavy menstrual bleeding has a normal pelvic ultrasound, normal coagulation screen, and no contraindications to hormonal therapy. She wishes to preserve fertility. What is the most appropriate first-line management?',\n correct: 'First-line management for heavy bleeding with a structurally normal uterus and no contraindications includes tranexamic acid or NSAIDs, or hormonal options such as combined oral contraceptives or the levonorgestrel IUS, reserving ablation or hysterectomy for medical failure once fertility is no longer a priority',\n opts: [\n 'First-line management for heavy bleeding with a structurally normal uterus and no contraindications includes tranexamic acid or NSAIDs, or hormonal options such as combined oral contraceptives or the levonorgestrel IUS, reserving ablation or hysterectomy for medical failure once fertility is no longer a priority',\n 'Because her heavy menstrual bleeding has been objectively confirmed rather than simply reported, endometrial ablation is the appropriate first-line option here, since objectively confirmed blood loss is generally considered to have crossed the threshold where medical therapy is unlikely to help',\n 'Hysterectomy is the most appropriate first step in this scenario, since medical therapy and conservative options generally only delay definitive treatment in women with confirmed heavy bleeding, regardless of her stated wish to preserve fertility going forward',\n 'Since her pelvic ultrasound and coagulation screen are both normal, no specific treatment is required beyond reassurance, as a structurally and haematologically normal evaluation indicates her heavy bleeding is not significant enough to warrant any active medical management at this time'\n ],\n exp: 'With a structurally normal uterus, normal coagulation, and no contraindications, the standard stepwise approach starts with <strong>medical therapy<\/strong> — tranexamic acid or NSAIDs for symptomatic relief during menses, or hormonal options like COCP or the levonorgestrel IUS for more sustained control — all effective, reversible, and fertility-preserving. <strong>Ablation and hysterectomy<\/strong> are reserved for medical failure or when fertility is no longer desired, not offered as a default first step. <br><br>\"Objectively confirmed\" blood loss <strong>confirms the diagnosis<\/strong>, not the treatment tier — it does not, by itself, justify skipping straight to surgery. And a <strong>normal workup<\/strong> doesn\\'t mean no treatment is warranted; it means the cause is non-structural and non-haematological, while the bleeding itself still merits symptomatic or hormonal management if it is bothering the patient.',\n imgId: null\n }\n\n ];\n\n var answers = {};\n var answered = 0;\n var shuffled = {};\n var done = false;\n\n function byId(id) { return document.getElementById(id); }\n function gid(suffix) { return byId(NS + '-' + suffix); }\n\n function shuffleArr(arr) {\n var a = arr.slice(), i, j, tmp;\n for (i = a.length - 1; i > 0; i--) {\n j = Math.floor(Math.random() * (i + 1));\n tmp = a[i]; a[i] = a[j]; a[j] = tmp;\n }\n return a;\n }\n\n function countVal(val) {\n var k, n = 0;\n for (k in answers) {\n if (answers.hasOwnProperty(k) && answers[k] === val) n++;\n }\n return n;\n }\n\n function buildPips() {\n var cont = gid('pips'), i, q, wLine, wPip, line, pip;\n cont.innerHTML = '';\n for (i = 0; i < QS.length; i++) {\n q = QS[i];\n if (i > 0) {\n wLine = document.createElement('div');\n wLine.className = 'mr-pip-wrap';\n line = document.createElement('div');\n line.className = 'mr-pip-line';\n line.id = NS + '-pl' + q.id;\n wLine.appendChild(line);\n cont.appendChild(wLine);\n }\n wPip = document.createElement('div');\n wPip.className = 'mr-pip-wrap';\n pip = document.createElement('div');\n pip.className = 'mr-pip';\n pip.id = NS + '-pip' + q.id;\n pip.textContent = String(q.id);\n wPip.appendChild(pip);\n cont.appendChild(wPip);\n }\n }\n\n function build() {\n var cont, i, q, opts, card, top, numDiv, meta, tag, stem,\n rule, optsDiv, expDiv, lbl, txt, imgDiv, imgSrc, j,\n optEl, ltrSpan, txtSpan;\n\n cont = gid('cases');\n cont.innerHTML = '';\n answers = {}; answered = 0; shuffled = {}; done = false;\n gid('score').style.display = 'none';\n buildPips();\n\n for (i = 0; i < QS.length; i++) {\n q = QS[i];\n opts = shuffleArr(q.opts);\n shuffled[q.id] = opts;\n\n card = document.createElement('div');\n card.className = 'mr-case';\n\n top = document.createElement('div');\n top.className = 'mr-case-top';\n\n numDiv = document.createElement('div');\n numDiv.className = 'mr-num';\n numDiv.textContent = q.id < 10 ? '0' + q.id : String(q.id);\n\n meta = document.createElement('div');\n meta.className = 'mr-meta';\n\n tag = document.createElement('div');\n tag.className = 'mr-tag';\n tag.innerHTML = q.tag;\n\n stem = document.createElement('div');\n stem.className = 'mr-stem';\n stem.innerHTML = q.stem;\n\n meta.appendChild(tag);\n meta.appendChild(stem);\n top.appendChild(numDiv);\n top.appendChild(meta);\n card.appendChild(top);\n\n rule = document.createElement('div');\n rule.className = 'mr-rule';\n card.appendChild(rule);\n\n optsDiv = document.createElement('div');\n optsDiv.className = 'mr-opts';\n\n for (j = 0; j < opts.length; j++) {\n optEl = document.createElement('div');\n optEl.className = 'mr-opt';\n optEl.id = NS + '-o' + q.id + '-' + j;\n optEl.setAttribute('role', 'button');\n optEl.setAttribute('tabindex', '0');\n\n ltrSpan = document.createElement('span');\n ltrSpan.className = 'mr-ltr';\n ltrSpan.textContent = LTRS[j];\n\n txtSpan = document.createElement('span');\n txtSpan.className = 'mr-opt-text';\n txtSpan.innerHTML = opts[j];\n\n optEl.appendChild(ltrSpan);\n optEl.appendChild(txtSpan);\n optsDiv.appendChild(optEl);\n\n (function (qid, oi) {\n optEl.addEventListener('click', function () { pick(qid, oi); });\n }(q.id, j));\n }\n card.appendChild(optsDiv);\n\n expDiv = document.createElement('div');\n expDiv.className = 'mr-exp';\n expDiv.id = NS + '-exp' + q.id;\n\n lbl = document.createElement('div');\n lbl.className = 'mr-exp-lbl';\n lbl.textContent = 'Debrief';\n\n txt = document.createElement('div');\n txt.className = 'mr-exp-text';\n txt.innerHTML = q.exp;\n\n expDiv.appendChild(lbl);\n expDiv.appendChild(txt);\n\n if (q.imgId) {\n imgSrc = byId(q.imgId);\n if (imgSrc) {\n imgDiv = document.createElement('div');\n imgDiv.innerHTML = imgSrc.innerHTML;\n expDiv.appendChild(imgDiv);\n }\n }\n\n card.appendChild(expDiv);\n cont.appendChild(card);\n }\n }\n\n function pick(qid, oi) {\n var q, opts, i, el, correct;\n if (answers[qid] !== undefined || done) return;\n\n q = null;\n for (i = 0; i < QS.length; i++) {\n if (QS[i].id === qid) { q = QS[i]; break; }\n }\n if (!q) return;\n\n opts = shuffled[qid];\n correct = (opts[oi] === q.correct);\n answers[qid] = correct ? 'c' : 'w';\n answered++;\n\n for (i = 0; i < opts.length; i++) {\n el = byId(NS + '-o' + qid + '-' + i);\n if (opts[i] === q.correct) {\n el.className = 'mr-opt correct locked';\n } else if (i === oi) {\n el.className = 'mr-opt wrong locked';\n } else {\n el.className = 'mr-opt dimmed locked';\n }\n }\n\n byId(NS + '-exp' + qid).style.display = 'block';\n byId(NS + '-pip' + qid).className = 'mr-pip ' + (correct ? 'correct' : 'wrong');\n\n if (qid > 1) {\n var pl = gid('pl' + qid);\n if (pl) pl.className = 'mr-pip-line done';\n }\n }\n\n function showScore() {\n var c, w, s, net, pct, disp, verdicts, vi, sc;\n if (done) return;\n done = true;\n\n c = countVal('c');\n w = countVal('w');\n s = TOTAL - answered;\n net = (c * 4) - w;\n pct = Math.max(0, Math.round((net \/ MAX) * 100));\n disp = Math.min(100, Math.max(0, pct));\n\n gid('ring').style.background =\n 'conic-gradient(#4B3A6E ' + disp + '%, #E0D8EC 0%)';\n\n gid('pct').textContent = pct + '%';\n gid('net').textContent = 'Net Score: ' + net + ' \/ ' + MAX;\n\n verdicts = [\n [5, 'Clean sweep \\u2014 PALM-COEIN logic is fully internalised.'],\n [4, 'Strong round \\u2014 one structural\/non-structural distinction to revisit.'],\n [3, 'Solid base \\u2014 the debrief will sharpen the fibroid-subtype and mechanism points.'],\n [2, 'Halfway there \\u2014 review the missed cases carefully.'],\n [0, 'AUB classification rewards close re-reading \\u2014 the structural-vs-non-structural line is the one to watch.']\n ];\n gid('verdict').textContent = verdicts[4][1];\n for (vi = 0; vi < verdicts.length; vi++) {\n if (c >= verdicts[vi][0]) {\n gid('verdict').innerHTML = verdicts[vi][1];\n break;\n }\n }\n\n gid('ct-c').textContent = '\\u2705 ' + c + ' Correct';\n gid('ct-w').textContent = '\\u274C ' + w + ' Wrong';\n gid('ct-s').textContent = '\\u23ED ' + s + ' Skipped';\n\n sc = gid('score');\n sc.style.display = 'block';\n sc.scrollIntoView({ behavior: 'smooth', block: 'center' });\n }\n\n function tryInit() {\n var sentinel = document.getElementById(NS + '-sentinel');\n var submit = document.getElementById(NS + '-submit');\n var retry = document.getElementById(NS + '-retry');\n if (!sentinel || !submit || !retry) {\n setTimeout(tryInit, 80);\n return;\n }\n submit.addEventListener('click', showScore);\n retry.addEventListener('click', function () {\n build();\n window.scrollTo(0, 0);\n });\n var bar = document.getElementById(NS + '-progress');\n if (bar && window.IntersectionObserver) {\n new IntersectionObserver(function (entries) {\n bar.className = entries[0].isIntersecting ? 'mr-progress' : 'mr-progress visible';\n }, { threshold: 0 }).observe(sentinel);\n }\n build();\n }\n\n tryInit();\n\n}());\n<\/script>\n\n\n\n","protected":false},"excerpt":{"rendered":"<p>Morning Rounds \u00b7 Abnormal Uterine Bleeding & PALM-COEIN Morning Rounds · Gynaecology Series · Round 02 Abnormal Uterine Bleeding &PALM-COEIN Five cases · Structural & non-structural causes of AUB · Trust your instinct 5 Cases +4 \/ −1 scoring Options reshuffled Submit for Debrief Round Complete 0% net Your Debrief ↻ New Round<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"","neve_meta_content_width":0,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","footnotes":""},"categories":[74,55],"tags":[82,93,83],"class_list":["post-37106","post","type-post","status-publish","format-standard","hentry","category-morning-rounds","category-obg","tag-cms","tag-gynaecology","tag-neet-pg"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Abnormal Uterine Bleeding & PALM-COEIN - atsixty<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/atsixty.com\/index.php\/obg\/abnormal-uterine-bleeding-palm-coein\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Abnormal Uterine Bleeding & PALM-COEIN - atsixty\" \/>\n<meta property=\"og:description\" content=\"Morning Rounds \u00b7 Abnormal Uterine Bleeding & PALM-COEIN Morning Rounds · Gynaecology Series · Round 02 Abnormal Uterine Bleeding &PALM-COEIN Five cases · Structural & non-structural causes of AUB · Trust your instinct 5 Cases +4 \/ −1 scoring Options reshuffled Submit for Debrief Round Complete 0% net Your Debrief ↻ New Round\" \/>\n<meta property=\"og:url\" content=\"https:\/\/atsixty.com\/index.php\/obg\/abnormal-uterine-bleeding-palm-coein\/\" \/>\n<meta property=\"og:site_name\" content=\"atsixty\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-26T00:14:59+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-26T00:15:51+00:00\" \/>\n<meta name=\"author\" content=\"Avi\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Avi\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/atsixty.com\\\/index.php\\\/obg\\\/abnormal-uterine-bleeding-palm-coein\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/atsixty.com\\\/index.php\\\/obg\\\/abnormal-uterine-bleeding-palm-coein\\\/\"},\"author\":{\"name\":\"Avi\",\"@id\":\"https:\\\/\\\/atsixty.com\\\/#\\\/schema\\\/person\\\/cf65e7ac7d8226d95c0bdf1036f7951d\"},\"headline\":\"Abnormal Uterine Bleeding & PALM-COEIN\",\"datePublished\":\"2026-06-26T00:14:59+00:00\",\"dateModified\":\"2026-06-26T00:15:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/atsixty.com\\\/index.php\\\/obg\\\/abnormal-uterine-bleeding-palm-coein\\\/\"},\"wordCount\":52,\"publisher\":{\"@id\":\"https:\\\/\\\/atsixty.com\\\/#\\\/schema\\\/person\\\/cf65e7ac7d8226d95c0bdf1036f7951d\"},\"keywords\":[\"CMS\",\"Gynaecology\",\"NEET-PG\"],\"articleSection\":[\"Morning Rounds\",\"OBG\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/atsixty.com\\\/index.php\\\/obg\\\/abnormal-uterine-bleeding-palm-coein\\\/\",\"url\":\"https:\\\/\\\/atsixty.com\\\/index.php\\\/obg\\\/abnormal-uterine-bleeding-palm-coein\\\/\",\"name\":\"Abnormal Uterine Bleeding & PALM-COEIN - atsixty\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/atsixty.com\\\/#website\"},\"datePublished\":\"2026-06-26T00:14:59+00:00\",\"dateModified\":\"2026-06-26T00:15:51+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/atsixty.com\\\/index.php\\\/obg\\\/abnormal-uterine-bleeding-palm-coein\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/atsixty.com\\\/index.php\\\/obg\\\/abnormal-uterine-bleeding-palm-coein\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/atsixty.com\\\/index.php\\\/obg\\\/abnormal-uterine-bleeding-palm-coein\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/atsixty.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Abnormal Uterine Bleeding & PALM-COEIN\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/atsixty.com\\\/#website\",\"url\":\"https:\\\/\\\/atsixty.com\\\/\",\"name\":\"At Sixty\",\"description\":\"The Option Taken\",\"publisher\":{\"@id\":\"https:\\\/\\\/atsixty.com\\\/#\\\/schema\\\/person\\\/cf65e7ac7d8226d95c0bdf1036f7951d\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/atsixty.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":[\"Person\",\"Organization\"],\"@id\":\"https:\\\/\\\/atsixty.com\\\/#\\\/schema\\\/person\\\/cf65e7ac7d8226d95c0bdf1036f7951d\",\"name\":\"Avi\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/atsixty.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/logo-agency.png\",\"url\":\"https:\\\/\\\/atsixty.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/logo-agency.png\",\"contentUrl\":\"https:\\\/\\\/atsixty.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/logo-agency.png\",\"width\":200,\"height\":200,\"caption\":\"Avi\"},\"logo\":{\"@id\":\"https:\\\/\\\/atsixty.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/logo-agency.png\"},\"sameAs\":[\"https:\\\/\\\/atsixty.com\"],\"url\":\"https:\\\/\\\/atsixty.com\\\/index.php\\\/author\\\/avinaux\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Abnormal Uterine Bleeding & PALM-COEIN - atsixty","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/atsixty.com\/index.php\/obg\/abnormal-uterine-bleeding-palm-coein\/","og_locale":"en_US","og_type":"article","og_title":"Abnormal Uterine Bleeding & PALM-COEIN - atsixty","og_description":"Morning Rounds \u00b7 Abnormal Uterine Bleeding & PALM-COEIN Morning Rounds · Gynaecology Series · Round 02 Abnormal Uterine Bleeding &PALM-COEIN Five cases · Structural & non-structural causes of AUB · Trust your instinct 5 Cases +4 \/ −1 scoring Options reshuffled Submit for Debrief Round Complete 0% net Your Debrief ↻ New Round","og_url":"https:\/\/atsixty.com\/index.php\/obg\/abnormal-uterine-bleeding-palm-coein\/","og_site_name":"atsixty","article_published_time":"2026-06-26T00:14:59+00:00","article_modified_time":"2026-06-26T00:15:51+00:00","author":"Avi","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Avi","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/atsixty.com\/index.php\/obg\/abnormal-uterine-bleeding-palm-coein\/#article","isPartOf":{"@id":"https:\/\/atsixty.com\/index.php\/obg\/abnormal-uterine-bleeding-palm-coein\/"},"author":{"name":"Avi","@id":"https:\/\/atsixty.com\/#\/schema\/person\/cf65e7ac7d8226d95c0bdf1036f7951d"},"headline":"Abnormal Uterine Bleeding & PALM-COEIN","datePublished":"2026-06-26T00:14:59+00:00","dateModified":"2026-06-26T00:15:51+00:00","mainEntityOfPage":{"@id":"https:\/\/atsixty.com\/index.php\/obg\/abnormal-uterine-bleeding-palm-coein\/"},"wordCount":52,"publisher":{"@id":"https:\/\/atsixty.com\/#\/schema\/person\/cf65e7ac7d8226d95c0bdf1036f7951d"},"keywords":["CMS","Gynaecology","NEET-PG"],"articleSection":["Morning Rounds","OBG"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/atsixty.com\/index.php\/obg\/abnormal-uterine-bleeding-palm-coein\/","url":"https:\/\/atsixty.com\/index.php\/obg\/abnormal-uterine-bleeding-palm-coein\/","name":"Abnormal Uterine Bleeding & PALM-COEIN - atsixty","isPartOf":{"@id":"https:\/\/atsixty.com\/#website"},"datePublished":"2026-06-26T00:14:59+00:00","dateModified":"2026-06-26T00:15:51+00:00","breadcrumb":{"@id":"https:\/\/atsixty.com\/index.php\/obg\/abnormal-uterine-bleeding-palm-coein\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/atsixty.com\/index.php\/obg\/abnormal-uterine-bleeding-palm-coein\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/atsixty.com\/index.php\/obg\/abnormal-uterine-bleeding-palm-coein\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/atsixty.com\/"},{"@type":"ListItem","position":2,"name":"Abnormal Uterine Bleeding & PALM-COEIN"}]},{"@type":"WebSite","@id":"https:\/\/atsixty.com\/#website","url":"https:\/\/atsixty.com\/","name":"At Sixty","description":"The Option Taken","publisher":{"@id":"https:\/\/atsixty.com\/#\/schema\/person\/cf65e7ac7d8226d95c0bdf1036f7951d"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/atsixty.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":["Person","Organization"],"@id":"https:\/\/atsixty.com\/#\/schema\/person\/cf65e7ac7d8226d95c0bdf1036f7951d","name":"Avi","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/atsixty.com\/wp-content\/uploads\/2025\/08\/logo-agency.png","url":"https:\/\/atsixty.com\/wp-content\/uploads\/2025\/08\/logo-agency.png","contentUrl":"https:\/\/atsixty.com\/wp-content\/uploads\/2025\/08\/logo-agency.png","width":200,"height":200,"caption":"Avi"},"logo":{"@id":"https:\/\/atsixty.com\/wp-content\/uploads\/2025\/08\/logo-agency.png"},"sameAs":["https:\/\/atsixty.com"],"url":"https:\/\/atsixty.com\/index.php\/author\/avinaux\/"}]}},"_links":{"self":[{"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/posts\/37106","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/comments?post=37106"}],"version-history":[{"count":1,"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/posts\/37106\/revisions"}],"predecessor-version":[{"id":37107,"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/posts\/37106\/revisions\/37107"}],"wp:attachment":[{"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/media?parent=37106"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/categories?post=37106"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/tags?post=37106"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}